# Jesduvroq

NDC: 0173-0897
Generic name: daprodustat
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230201
Marketing ended: 20270131
FDA application: NDA216951

## Active ingredients

- DAPRODUSTAT: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0897"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0897
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d82aa06e-5a33-4844-99b7-4701313455a4
